Yi Shen

ORCID: 0009-0005-3523-3431 · 9 papers in corpus · active 2021-2026

Study types

  • article 3
  • other 2
  • review 2

Condition tags

  • endometriosis 3
  • adenomyosis 2
review 2026
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-026-02050-6

The uterine cavity was formerly considered sterile; however, over recent years, researchers have identified the presence of endometrial microbiota. An imbalance in the endometrial microbiota, or dysbiosis, has been shown to be associated wi…

other 2026
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.70283

PURPOSE: To investigate the association between dendritic cell maturation deficits and pain in patients with adenomyosis and explore potential neuro-immune mechanisms. METHODS: Uterine tissues from 24 patients with adenomyosis (AM) and 15 …

other 2025
International immunopharmacology ·doi:10.1016/j.intimp.2025.114072

OBJECTIVE: The endometrial microbiota exerts a crucial role in maintaining the health of the female reproductive system. As such, in this study, we have examined the composition of the microbiota in endometrium tissues with and without endo…

article 2023
·doi:10.1016/j.heliyon.2023.e20716

Background: Intrauterine adhesions (IUAs) are a common illness of the uterine cavity. Endometrial fibrosis is the main pathological feature. In addition to a high recurrence rate, patients with severe IUAs have a low pregnancy rate. However…

article 2023
Clinical therapeutics ·doi:10.1016/j.clinthera.2023.07.019
article 2023
·doi:10.21037/gpm-25-18

Background: Hyperprolactinemia is commonly caused by pituitary prolactinomas or medications and is typically managed with dopamine agonists (DAs). However, ectopic prolactin secretion from non-pituitary sources is rare and often unresponsiv…

review 2022
International immunopharmacology ·doi:10.1016/j.intimp.2022.109452
2021
·doi:10.21203/rs.3.rs-1038856/v1
2021
·doi:10.21203/rs.3.rs-775523/v1